WuXi Biologics’ Irish Site Awarded Three Authoritative ISO International Standard System Certifications

March 5, 2024  Source: drugdu 81

"/Dundalk, Ireland, March 1, 2024 - WuXi Biologics (2269.HK), a leading global contract research, development and manufacturing (CRDMO) services company, announced that its Dundalk, Ireland site has recently been awarded three authoritative ISO (International Organization for Standardization) accreditations at the same time, including ISO 50001 Energy Management System, ISO 14001 Environmental Management System and ISO 45001 Occupational Health and Safety Management System. ISO 50001 Energy Management System Certification, ISO 14001 Environmental Management System Certification and ISO 45001 Occupational Health and Safety Management System Certification, fully demonstrating that WuXi Biologics has always been adhering to the ESG (Environmental, Social and Governance) development strategy, and has consistently adhered to international standards and achieved outstanding results in environmental protection, sustainable energy development and employee health and safety.

As a model for WuXi Biologics' future factory, the Ireland site has been actively optimizing energy use, improving efficiency and reducing waste emissions from operations, and by 2023, the site has achieved a 100% renewable electricity supply, reduced electricity consumption by 170 million watt-hours and natural gas consumption by 340 million watt-hours. In addition, the site has made substantial progress in waste minimization and upgrading waste treatment capacity. As a result of this environmental and energy management excellence, the Ireland site has been awarded ISO 50001 Energy Management System Certification and ISO 14001 Environmental Management System Certification. In addition, the site has passed the ISO 45001 Occupational Health and Safety Management System Certification for its adherence to the highest standards of occupational health and safety and the creation of a safe and healthy office environment.

https://mp.weixin.qq.com/s/z2z7o3pZl8U9rbU39wev4Q

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.